Xponance’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-2,433
Closed -$207K – 1277
2023
Q3
$207K Sell
2,433
-234
-9% -$22.2K ﹤0.01% 1114
2023
Q2
$291K Sell
2,667
-139
-5% -$13.2K ﹤0.01% 1060
2023
Q1
$233K Buy
2,806
+28
+1% +$2.64K ﹤0.01% 1095
2022
Q4
$286K Buy
2,778
+120
+5% +$13.8K ﹤0.01% 1045
2022
Q3
$281K Buy
2,658
+221
+9% +$24.2K 0.01% 1009
2022
Q2
$267K Buy
2,437
+183
+8% +$18.1K 0.01% 1037
2022
Q1
$235K Buy
2,254
+14
+0.6% +$1.45K ﹤0.01% 1075
2021
Q4
$274K Buy
2,240
+9
+0.4% +$999 ﹤0.01% 1057
2021
Q3
$256K Sell
2,231
-351
-14% -$37.2K ﹤0.01% 1074
2021
Q2
$250K Buy
+2,582
New +$224K ﹤0.01% 1112

Other funds holding AMN

Xponance's AMN Position: Q4 2023 in Review

Xponance sold out of AMN Healthcare (AMN) in Q4 2023, closing a stake of 2,433 shares — an estimated $207K sold.

Xponance first reported a position in AMN in Q2 2021 and held it in 10 quarters. The position peaked at $291K in Q2 2023. 381 funds tracked by Wall St. Rank hold AMN as of Q4 2023.

  • Xponance reported no remaining AMN Healthcare position as of Q4 2023 after selling out during the quarter.
  • Xponance sold 2,433 AMN Healthcare shares in Q4 2023, an estimated $207K.
  • Xponance first reported a position in AMN Healthcare in Q2 2021 and held it in 10 quarters.
  • Xponance's AMN Healthcare position peaked at $291K in Q2 2023.
  • 381 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2023.

Based on Xponance's 13F filing for Q4 2023, filed 31 Jan 2024.